Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/6/2018
SIETES contiene 92381 citas

 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Gargiulo G, Windecker S, da Costa BR, Feres F, Hong M-K, Gilard M, Kim H-S, Colombo A, Bhatt DL, Kim B-K, Morice M-C, Park KW, Chieffo A, Palmerini T, Stone GW, Valgimigli M. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ 2016;355:i5483. [Ref.ID 100878]
2.Enlace a cita original
Kim H-S, Lim Y, Oh M, Ghim J-I, Kim E-Y, Kim DH, Shin J-G. The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes. Br J Clin Pharmacol 2016;81:301-12. [Ref.ID 100147]
3.Tiene citas relacionadas Cita con resumen
Palmerini T, Benedetto U, Bacchi-Reggiani L, Della Riva D, Biondi-Zoccai G, Feres F, Abizaid A, Hong M-K, Kim B-K, Jang Y, Kim H-S, Park KW, Genereux P, Bhatt DL, Orlandi C, De Servi S, Petrou M, Rapezzi C, Stone GW. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials. Lancet 2015;385:2371-82. [Ref.ID 99292]
4. Cita con resumen
Lee CW, Ahn J-M, Park DW, Kang S-J, Lee S-W, Kim Y-H, Park SW, Han S, Lee S-G, Seong I-W, Rha S-W, Jeong M-H, Lim D-S, Yoon J-H, Hur S-H, Choi Y-S, Yang J-Y, Lee N-H, Kim H-S, Lee B-K, Kim K-S, Lee S-U, Chae J-K, Cheong S-S, Suh I-w, Park HS, Nah D-Y, Jeon D-S, Seung K-B, Lee K, Jang J-S, Park SJ. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized controlled trial. Circulation 2014;129:304-12. [Ref.ID 96224]
5.Tiene citas relacionadas Cita con resumen
Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D'Ascenzo F, Kimura T, Briguori C, Sabaté M, Kim H-S, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012;379:1393-402. [Ref.ID 92725]
Seung KB, Park DW, Kim Y-H, Lee S-W, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong M-H, Jang Y, Kim H-S, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Stent versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008;358:1781-92. [Ref.ID 82720]
7.Tiene citas relacionadas Cita con resumen
Koo B-K, Kim Y-S, Park KW, Yang HM, Kwon D-A, Chung JW, Hahn JY, Lee H-Y, Park JS, Kang H-J, Cho YS, Youn TJ, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Kim H-S. Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study. Lancet 2007;370:567-74. [Ref.ID 80808]
Suh JW, Koo B-K, Zhang SY, Park KW, Cho JY, Jang I-J, Lee D-S, Sohn DW, Lee M-M, Kim H-S. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. Can Med Assoc J 2006;174:1715-22. [Ref.ID 77064]
Seleccionar todas
 1 a 9 de 9